24 research outputs found

    ACSL6 Is Associated with the Number of Cigarettes Smoked and Its Expression Is Altered by Chronic Nicotine Exposure

    Get PDF
    Individuals with schizophrenia tend to be heavy smokers and are at high risk for tobacco dependence. However, the nature of the comorbidity is not entirely clear. We previously reported evidence for association of schizophrenia with SNPs and SNP haplotypes in a region of chromosome 5q containing the SPEC2, PDZ-GEF2 and ACSL6 genes. In this current study, analysis of the control subjects of the Molecular Genetics of Schizophrenia (MGS) sample showed similar pattern of association with number of cigarettes smoked per day (numCIG) for the same region. To further test if this locus is associated with tobacco smoking as measured by numCIG and FTND, we conducted replication and meta-analysis in 12 independent samples (n>16,000) for two markers in ACSL6 reported in our previous schizophrenia study. In the meta-analysis of the replication samples, we found that rs667437 and rs477084 were significantly associated with numCIG (p = 0.00038 and 0.00136 respectively) but not with FTND scores. We then used in vitro and in vivo techniques to test if nicotine exposure influences the expression of ACSL6 in brain. Primary cortical culture studies showed that chronic (5-day) exposure to nicotine stimulated ACSL6 mRNA expression. Fourteen days of nicotine administration via osmotic mini pump also increased ACSL6 protein levels in the prefrontal cortex and hippocampus of mice. These increases were suppressed by injection of the nicotinic receptor antagonist mecamylamine, suggesting that elevated expression of ACSL6 requires nicotinic receptor activation. These findings suggest that variations in the ACSL6 gene may contribute to the quantity of cigarettes smoked. The independent associations of this locus with schizophrenia and with numCIG in non-schizophrenic subjects suggest that this locus may be a common liability to both conditions

    Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

    Get PDF
    Background: Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. // Methods: We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung's disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. // Findings: We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung's disease) from 264 hospitals (89 in high-income countries, 166 in middle-income countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in low-income countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. // Interpretation: Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between low-income, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

    Integral Prospection of Andean Microbial Ecosystem Project

    No full text
    When microbial ecosystems first started to be reported 10 years ago, nobody reallyhad a notion of the relevance they would have in the Central Andean region.Consequently, the heritage of the microbialites reported in El Peinado, LagunaNegra, Laguna Pozo Bravo, Laguna La Brava, etc. promises to position the Andes asreservoirs of the most relevant modern microbialites on the planet (Table 17.1,Fig. 17.1). Furthermore, the number of different ecosystems is worth paying closeattention to, as it gives rise to questions such as: What favors the development ofthese ecosystems? What are the conditions that influence the precipitation of a carbonaceousor a gypsum system at such a short distance and under similar environmentalconditions, such as at the Atacama salt flat? Why are oncolites distributed so? Untilnow, it has been possible only to survey the systems and to carry out more in-depthstudies in some of them to try to achieve their preservation. Throughout the prospection of the Andean microbial ecosystems (AMEs), some shared characteristics have beenfound from the geological, physical, and chemical points of view [(1) active volcanicincidence: all of the microbial ecosystems that have been found are in some way connectedto areas where active volcanoes are present; (2) underground water input;(3) mixed zones with different salinities: underground low-conductivitywater andsalar thalassic water; (4) two kinds of microbialites found: oncolites (at LagunaNegra, Tres Quebradas, Las Quinoas, etc.) or domes with thrombolites at the bottomand stromatolites at the top surface (at La Brava, Pozo Bravo, Ojos Bravos, and ElPeinado)] and from the biological point of view [(5) predominance of diatoms, themain component in all studied systems; (6) predominance of anaerobic over aerobicphotosynthetic microorganisms; (7) microbial rhodopsin as the main system for producing adenosine triphosphate (ATP); (8) arsenicresistance and bioenergetic mechanisms;and (9) predominance of Carbon fixation pathways other than the Calvincycle]. The biological aspects of these are being studied thoroughly in our lab and arebriefly discussed below.Fil: Farias, Maria Eugenia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Planta Piloto de Procesos Industriales Microbiológicos; ArgentinaFil: Villafañe, Patricio Guillermo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Planta Piloto de Procesos Industriales Microbiológicos; ArgentinaFil: Lencina, Agustina Inés. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Investigaciones y Transferencia de Catamarca. Universidad Nacional de Catamarca. Centro de Investigaciones y Transferencia de Catamarca; Argentin

    Theoretical Study of Oxygen Reduction Reaction Catalysts: From Pt to Non-precious Metal Catalysts

    No full text
    Fuel cells are regarded as one of the most promising candidates for stationary and mobile power generation due to their high energy yield and low environmental impact of hydrogen oxidation. The oxygen reduction reaction (ORR) at cathode is a very complex process and plays a crucial role during operation of the PEM fuel cells. However, its mechanism and the nature of intermediates involved remain vague. This chapter focuses on the recent theoretical modeling studies of ORR catalysts for PEMFC. Recent theoretical investigations on oxygen reduction electrocatalysts, such as Pt-based catalysts, non-Pt metal catalysts (Pd, Ir, CuCl), and non-precious metal catalysts (transitional metal macrocyclic complexes, conductive polymer materials, and carbon-based materials), are reviewed. The oxygen reduction mechanisms catalyzed by these catalysts are discussed based on the results. ? Springer-Verlag London 2013.EI0339-373
    corecore